Zurcher Kantonalbank (Zurich Cantonalbank) - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 202 filers reported holding REATA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.5%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$652,238
+10.4%
6,397
-1.5%
0.00%0.0%
Q1 2023$590,707
+194.7%
6,497
+23.1%
0.00%
+200.0%
Q4 2022$200,435
+77.4%
5,276
+17.6%
0.00%0.0%
Q3 2022$113,000
-17.5%
4,485
-0.4%
0.00%0.0%
Q2 2022$137,000
-11.0%
4,505
-4.0%
0.00%0.0%
Q1 2022$154,000
+24.2%
4,695
-0.4%
0.00%0.0%
Q4 2021$124,000
-73.8%
4,714
-0.0%
0.00%
-66.7%
Q3 2021$474,000
-23.5%
4,715
+7.7%
0.00%0.0%
Q2 2021$620,000
+144.1%
4,378
+71.9%
0.00%
+50.0%
Q1 2021$254,000
-27.2%
2,547
-9.8%
0.00%0.0%
Q4 2020$349,000
+39.0%
2,823
+9.4%
0.00%0.0%
Q3 2020$251,000
-37.7%
2,5800.0%0.00%
-33.3%
Q2 2020$403,000
+59.3%
2,580
+47.2%
0.00%
+50.0%
Q1 2020$253,000
-7.3%
1,753
+31.5%
0.00%0.0%
Q4 2019$273,000
+173.0%
1,333
+7.5%
0.00%
+100.0%
Q3 2019$100,000
+6.4%
1,240
+25.1%
0.00%0.0%
Q2 2019$94,000
+10.6%
9910.0%0.00%0.0%
Q1 2019$85,000
+203.6%
991
+100.2%
0.00%
Q4 2018$28,000
-30.0%
4950.0%0.00%
Q3 2018$40,0004950.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Conrad N. Hilton Foundation 63,481$7,847,000100.00%
CPMG Inc 2,896,901$358,115,00055.16%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 140,000$17,307,00026.62%
Corriente Advisors, LLC 525,000$64,901,00015.45%
DUMAC, INC. 76,050$9,401,0007.33%
MADDEN SECURITIES Corp 35,152$4,345,0002.80%
Biondo Investment Advisors, LLC 113,692$14,055,0002.69%
Duquesne Family Office 749,897$92,702,0002.50%
LBJ Family Wealth Advisors, Ltd. 30,368$3,754,0002.44%
Integral Health Asset Management, LLC 50,000$6,181,0001.84%
View complete list of REATA PHARMACEUTICALS INC shareholders